Cargando…
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome
IMPORTANCE: Determining whether neurofilament light chain (NfL) elevations in patients who develop immune effector cell–associated neurotoxicity syndrome (ICANS) occur before or after infusion of cellular product is important to identify high-risk patients and inform whether neuroaxonal injury is la...
Autores principales: | Butt, Omar H., Zhou, Alice Y., Caimi, Paolo F., Luckett, Patrick H., Wisch, Julie K., Derenoncourt, Paul-Robert, Lee, Kenneth, Wu, Gregory F., de Lima, Marcos J. G., Campian, Jian L., Frank, Matthew J., DiPersio, John F., Ghobadi, Armin, Ances, Beau M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437827/ https://www.ncbi.nlm.nih.gov/pubmed/36048456 http://dx.doi.org/10.1001/jamaoncol.2022.3738 |
Ejemplares similares
-
A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome
por: Butt, Omar H., et al.
Publicado: (2023) -
CLRM-10. THE INTER-RELATIONSHIP BETWEEN MULTI-MODAL LONGITUDINAL BIOMARKERS OF NEURAL DAMAGE, INFLAMMATION, AND COGNITION AFTER CAR T CELLULAR THERAPY: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL TRIAL (NCT04614987)
por: Butt, Omar, et al.
Publicado: (2021) -
Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?
por: Goldsmith, Scott R., et al.
Publicado: (2020) -
Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice
por: Kitanaka, Nobue, et al.
Publicado: (2015) -
Changes in Interictal Pretreatment and Posttreatment EEG in Childhood Absence Epilepsy
por: Glaba, Pawel, et al.
Publicado: (2020)